Ozempic is the brand name for semaglutide. This is a prescription drug responsible for managing diabetes by controlling blood sugar levels. It increases insulin production in the pancreas and reduces the production of glucose in the liver. Consequently, it reduces the weight as well.
However, it is important to know about semaglutide before using it. In this blog, you will learn all there is to know about Ozempic.
What is Ozempic?
Ozempic is an FDA-approved semaglutide that is used for adults with type 2 diabetes. It is a weekly injection that lowers the blood sugar by supporting the pancreas to make more insulin. Furthermore, it stimulates the production of a hormone known as GLP-1, which leads to the creation of more insulin. This insulin, consequently, promotes the absorption of glucose by the cells. Hence, it is converted into energy.
Subsequently, GLP-1 limits the production of glucose in the liver, slowing down the digestive process. Moreover, it reduces the risk of a spike in blood sugar after a meal. This is because it also slows down the digestive process.
How does Ozempic work for weight loss?
This drug works by mimicking a hormone, GLP-1, that occurs naturally. When the levels of the hormones rise, the molecules of the drug travel to the brain. It sends a message telling the brain that you’re full. The digestion slows down, taking time for the food to leave the body.
Connection of GLP-1 and weight loss
Semaglutide, a GLP-1 receptor agonist, has gained the attention of social media for its ability to reduce weight. This, essentially, slows down the stomach from emptying, hence making you feel full for longer. As a result, you tend to reduce your food intake.
Research shows that participants using GLP-1s lost an average of 10% to 15% of their body weight within the year.
Benefits of GLP-1 agonists
GLP-1 drugs, like Ozempic, lower blood sugar levels. Furthermore, this medication may also help treat or lower the risk of other conditions. Those conditions are:
- Colon cancer: A recent study shows that GLP-1 medicine, such as Ozempic, lowers the rate of colorectal cancer in those who have type 2 diabetes, as compared to those taking antidiabetic medications.
- Heart attack and stroke: The FDA had an announcement that GLP-1 medicine, Wegovy, now reduces the risk of cardiovascular death, stroke, and heart attack in people who are overweight or obese.
- Kidney disease: A clinical trial reports that the group of people subjected to semaglutide showed a reduction in kidney disease production as well as kidney death by 24%.
To Sum It Up
Ozempic and other GLP-1 receptor agonists have shown signs that they also reduce weight, along with other benefits. The most significant thing is to consult the doctor for your problems and let them diagnose your condition.
Contact the Internal Medicine Diagnostic Centre and get the best medical services required to address your problems. You can call us at (281) 252-8600 and request an appointment.